fluorodeoxyglucose f18 has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 19 (95.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartenstein, P; Buchholz, HG; Glaser, M; Klimpe, S; Landvogt, C; Müller-Forell, W; Piel, M; Rösch, F; Schreckenberger, M; Siessmeier, T; Werhahn, KJ; Yakushev, I | 1 |
| Blockx, I; Boisgard, R; Dollé, F; Dubois, A; Jego, B; Jonckers, E; Kuhnast, B; Nguyen, HP; Raber, K; Siquier, K; Tavitian, B; Van Camp, N; Van der Linden, A; Verhoye, M; Von Hörsten, S | 1 |
| Bormans, G; Ceccarini, J; Claes, S; Demyttenaere, K; Pizzagalli, DA; Van Laere, K; Vandenbulcke, M; Vrieze, E | 1 |
| Brown, AK; Farahi, J; Ghahremani, DG; London, ED; Mandelkern, MA; Moallem, N; Robertson, C; Sumerel, B | 1 |
| Christian, BT; Colzato, LS; Davidson, RJ; Fox, AS; King, CR; Murali, D; Slagter, HA; Tomer, R | 1 |
| Ginovart, N; Ibanez, V; Millet, P; Moulin-Sallanon, M; Steimer, T; Tournier, BB | 1 |
| Ginovart, N; Ibañez, V; Millet, P; Moulin-Sallanon, M; Steimer, T; Tournier, BB; Vallet, P | 1 |
| Baker, S; Clark-Papasavas, C; Cleij, M; Dunn, JT; Howard, R; Kapur, S; Kessler, R; Marsden, P; Reeves, SJ | 1 |
| Acosta-Cabronero, J; Aigbirhio, FI; Baron, JC; Brichard, L; Chamberlain, SR; del Campo, N; Dowson, J; Fryer, TD; Hong, YT; Izquierdo, D; Müller, U; Regenthal, R; Robbins, TW; Sahakian, BJ; Smith, R; Suckling, J; Tait, R | 1 |
| Bilder, R; Borg, J; Brown, AK; Cannon, T; Ghahremani, DG; Ishibashi, K; London, ED; Mandelkern, MA; Robertson, CL; Sabb, F | 1 |
| Dean, AC; Kohno, M; London, ED; Mandelkern, MA; Morales, AM; Robertson, CL | 1 |
| Kato, K; Kunugi, H; Masuda, C; Ogawa, S; Ota, M | 1 |
| Colloca, L; Feier, NA; Hong, JY; Jarcho, JM; Labus, JS; London, ED; Mandelkern, MA; Mayer, EA; Naliboff, B; Smith, SR; Tillisch, K | 1 |
| Diaz, MP; Michopoulos, V; Wilson, ME | 1 |
| Dean, AC; London, ED; Mandelkern, MA; Okita, K; Petersen, N; Robertson, CL | 1 |
| Albert, NL; Bartenstein, P; Boetzel, K; Cumming, P; Deutschländer, A; Gildehaus, FJ; la Fougère, C; Xiong, G | 1 |
| Chao, PH; Hanet, S; van Dam, RM; Wang, J | 1 |
| Claassen, DO; Deutch, AY; Donahue, MJ; Kessler, RM; Petersen, KJ; Smith, CT; Stark, AJ; Trujillo, P; van Wouwe, NC; Zald, DH | 1 |
| Beck, MCH; Booij, J; Ceccarini, J; Frank, M; Heinzel, A; Hernaus, D; Kasanova, Z; Mohammadkhani-Shali, S; Mottaghy, F; Myin-Germeys, I; van Amelsvoort, T; van Duin, EDA; Winz, O | 1 |
| Arcolin, M; Bongarzone, S; Cash, D; Gee, A; Marsden, PK; O'Doherty, J; Sementa, T; Simmons, C; Singh, N; Turkheimer, FE; Veronese, M | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
| Article | Year |
|---|---|
Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.
Topics: Aged; Aging; Benzamides; Brain; Brain Mapping; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2013 |
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzamides; Corpus Striatum; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Methylphenidate; Multimodal Imaging; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Young Adult | 2013 |
18 other study(ies) available for fluorodeoxyglucose f18 and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
| Article | Year |
|---|---|
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
Topics: Adult; Benzamides; Brain Mapping; Electroencephalography; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Sclerosis; Temporal Lobe; Tissue Distribution; Videotape Recording | 2006 |
Genotype specific age related changes in a transgenic rat model of Huntington's disease.
Topics: Aging; Animals; Autoradiography; Benzamides; Biomarkers; Brain; Cerebral Ventricles; Corpus Striatum; Diffusion Tensor Imaging; Fluorodeoxyglucose F18; Genotype; Huntington Disease; Image Processing, Computer-Assisted; Male; Phenotype; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Rats; Rats, Transgenic | 2011 |
Measuring extrastriatal dopamine release during a reward learning task.
Topics: Adult; Benzamides; Brain Mapping; Cerebral Cortex; Dopamine; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Probability Learning; Reaction Time; Reward; Surveys and Questionnaires | 2013 |
Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers.
Topics: Adult; Analysis of Variance; Benzamides; Corpus Striatum; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Receptors, Dopamine D2; Receptors, Dopamine D3; Sex Characteristics; Smoking; Young Adult | 2012 |
PET evidence for a role for striatal dopamine in the attentional blink: functional implications.
Topics: Adult; Analysis of Variance; Attentional Blink; Benzamides; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Photic Stimulation; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Young Adult | 2012 |
Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.
Topics: Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Benzamides; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fluorodeoxyglucose F18; Gene Expression Regulation; Locomotion; Male; Nucleus Accumbens; Positron-Emission Tomography; Protein Binding; Psychotropic Drugs; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Tritium; Vitamin K 1 | 2012 |
Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Animals; Benzamides; Benzopyrans; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Fluorodeoxyglucose F18; Male; Motor Activity; Oxazines; Rats; Receptors, Dopamine D2; Reflex, Startle; Tritium; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.
Topics: Adult; Benzamides; Benzazepines; Benzofurans; Choice Behavior; Corpus Striatum; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Receptors, Dopamine D1; Receptors, Dopamine D2; Regression Analysis; Young Adult | 2015 |
Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
Topics: Benzamides; Dopamine Antagonists; Drug-Seeking Behavior; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mesencephalon; Methamphetamine; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Regression Analysis; Substance-Related Disorders; Time Factors | 2015 |
Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Topics: Animals; Benzamides; Brain; Callithrix; Central Nervous System Stimulants; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Fluorodeoxyglucose F18; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia | 2015 |
Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.
Topics: Adult; Analgesia; Benzamides; Brain; Dopamine; Female; Fluorodeoxyglucose F18; Hot Temperature; Humans; Magnetic Resonance Imaging; Pain Perception; Placebo Effect; Positron-Emission Tomography; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Report; Young Adult | 2016 |
Social change and access to a palatable diet produces differences in reward neurochemistry and appetite in female monkeys.
Topics: Agonistic Behavior; Analysis of Variance; Animals; Benzamides; Brain; Dietary Fats; Dominance-Subordination; Dopamine Antagonists; Eating; Energy Intake; Female; Fluorodeoxyglucose F18; Food Preferences; Hydrocortisone; Macaca mulatta; Positron-Emission Tomography; Reward; Social Behavior; Stress, Psychological | 2016 |
Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.
Topics: Adolescent; Adult; Analysis of Variance; Benzamides; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Positron-Emission Tomography; Receptors, Dopamine D2; Sex Characteristics; Tobacco Use Disorder; Young Adult | 2016 |
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients.
Topics: Aged; Benzamides; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Pramipexole; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2016 |
Performing multi-step chemical reactions in microliter-sized droplets by leveraging a simple passive transport mechanism.
Topics: Animals; Benzamides; Brain; Electrowetting; Female; Fluorodeoxyglucose F18; Mice; Mice, Inbred BALB C; Microfluidic Analytical Techniques; Microfluidics; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioactive Tracers | 2017 |
[
Topics: Aged; Aged, 80 and over; Benzamides; Brain Mapping; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Parkinson Disease; Positron-Emission Tomography; Receptors, Dopamine D2 | 2018 |
Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
Topics: Adult; Benzamides; Brain Mapping; Catechol O-Methyltransferase; Corpus Striatum; DiGeorge Syndrome; Dopamine; Dopamine D2 Receptor Antagonists; Female; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Learning Disabilities; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Mutation; Positron-Emission Tomography; Reinforcement, Psychology; Task Performance and Analysis; Valine | 2018 |
Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging.
Topics: Administration, Intranasal; Animals; Benzamides; Brain; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Male; Olfactory Bulb; Positron Emission Tomography Computed Tomography; Pyrrolidines; Radiochemistry; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2018 |